BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 17506377)

  • 1. Topical immunosuppressants, genital lichen sclerosus and the risk of squamous cell carcinoma: a case report.
    Fischer G; Bradford J
    J Reprod Med; 2007 Apr; 52(4):329-31. PubMed ID: 17506377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pimecrolimus for the treatment of vulvar lichen sclerosus: a report of 4 cases.
    Goldstein AT; Marinoff SC; Christopher K
    J Reprod Med; 2004 Oct; 49(10):778-80. PubMed ID: 15568399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pimecrolimus for the treatment of vulvar lichen sclerosus in a premenarchal girl.
    Goldstein AT; Marinoff SC; Christopher K
    J Pediatr Adolesc Gynecol; 2004 Feb; 17(1):35-7. PubMed ID: 15010037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vulvar lichen sclerosus: 11 women treated with tacrolimus 0.1% ointment.
    Virgili A; Lauriola MM; Mantovani L; Corazza M
    Acta Derm Venereol; 2007; 87(1):69-72. PubMed ID: 17225019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment of vulvar lichen sclerosus in a child with low-concentration topical tacrolimus ointment.
    Matsumoto Y; Yamamoto T; Isobe T; Kusunoki T; Tsuboi R
    J Dermatol; 2007 Feb; 34(2):114-6. PubMed ID: 17239148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vulvar lichen sclerosus: effect of maintenance treatment with a moisturizer on the course of the disease.
    Simonart T; Lahaye M; Simonart JM
    Menopause; 2008; 15(1):74-7. PubMed ID: 17603391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of topical pimecrolimus on inflammatory infiltrate in vulvar lichen sclerosus.
    Kauppila S; Kotila V; Knuuti E; Väre PO; Vittaniemi P; Nissi R
    Am J Obstet Gynecol; 2010 Feb; 202(2):181.e1-4. PubMed ID: 19889396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pimecrolimus 1% cream in the treatment of vulvar lichen sclerosus in postmenopausal women.
    Oskay T; Sezer HK; Genç C; Kutluay L
    Int J Dermatol; 2007 May; 46(5):527-32. PubMed ID: 17472689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histopathologic study of thin vulvar squamous cell carcinomas and associated cutaneous lesions: a correlative study of 48 tumors in 44 patients with analysis of adjacent vulvar intraepithelial neoplasia types and lichen sclerosus.
    Chiesa-Vottero A; Dvoretsky PM; Hart WR
    Am J Surg Pathol; 2006 Mar; 30(3):310-8. PubMed ID: 16538050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind, randomized controlled trial of clobetasol versus pimecrolimus in patients with vulvar lichen sclerosus.
    Goldstein AT; Creasey A; Pfau R; Phillips D; Burrows LJ
    J Am Acad Dermatol; 2011 Jun; 64(6):e99-104. PubMed ID: 21353334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical calcineurin inhibitors for the treatment of vulvar dermatoses.
    Goldstein AT; Thaçi D; Luger T
    Eur J Obstet Gynecol Reprod Biol; 2009 Sep; 146(1):22-9. PubMed ID: 19631446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical pimecrolimus in the treatment of genital lichen planus: a prospective case series.
    Lonsdale-Eccles AA; Velangi S
    Br J Dermatol; 2005 Aug; 153(2):390-4. PubMed ID: 16086755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Topical treatment of vulvar lichen sclerosus with calcineurin inhibitors].
    Maassen MS; van Doorn HC
    Ned Tijdschr Geneeskd; 2012; 156(36):A3908. PubMed ID: 22951124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of treatments on prognosis for vulvar lichen sclerosus: facts and controversies.
    Brodrick B; Belkin ZR; Goldstein AT
    Clin Dermatol; 2013; 31(6):780-6. PubMed ID: 24160287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind, randomized prospective study evaluating topical clobetasol propionate 0.05% versus topical tacrolimus 0.1% in patients with vulvar lichen sclerosus.
    Funaro D; Lovett A; Leroux N; Powell J
    J Am Acad Dermatol; 2014 Jul; 71(1):84-91. PubMed ID: 24704090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of angiogenesis and COX-2 expression in the evolution of vulvar lichen sclerosus to squamous cell carcinoma of the vulva.
    Raspollini MR; Asirelli G; Taddei GL
    Gynecol Oncol; 2007 Sep; 106(3):567-71. PubMed ID: 17560634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of prescribing topical corticosteroids to patients with lichen sclerosus following surgery for vulvar cancer: a survey among gynaecologic oncologists in The Netherlands.
    Voss FO; Groenewegen KL; Vermaat H; Bleeker MCG; van Beurden M
    J Obstet Gynaecol; 2024 Dec; 44(1):2294330. PubMed ID: 38156715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical tacrolimus for recalcitrant vulvar lichen sclerosus.
    SOTIRIOU E; APALLA Z; PATSATSI A; PANAGIOTIDOU D
    Eur J Dermatol; 2009; 19(5):515-6. PubMed ID: 19502156
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinically identifying women with vulvar lichen sclerosus at increased risk of squamous cell carcinoma: a case-control study.
    Jones RW; Sadler L; Grant S; Whineray J; Exeter M; Rowan D
    J Reprod Med; 2004 Oct; 49(10):808-11. PubMed ID: 15568404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vulvar lichen sclerosus successfully treated with topical tacrolimus.
    Ginarte M; Toribio J
    Eur J Obstet Gynecol Reprod Biol; 2005 Nov; 123(1):123-4. PubMed ID: 16260345
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.